TrialJournal of the American Society of Nephrology : JASN2018

Empagliflozin and Kidney Function Decline in Patients with Type 2 Diabetes: A Slope Analysis from the EMPA-REG OUTCOME Trial.

Christoph Wanner et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.